BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14696222)

  • 41. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
    Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
    Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.
    Thakur SB; Horvat JV; Hancu I; Sutton OM; Bernard-Davila B; Weber M; Oh JH; Marino MA; Avendano D; Leithner D; Brennan S; Giri D; Manderski E; Morris EA; Pinker K
    J Magn Reson Imaging; 2019 Jul; 50(1):239-249. PubMed ID: 30605266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
    J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
    Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
    J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
    Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
    Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).
    Danishad KK; Sharma U; Sah RG; Seenu V; Parshad R; Jagannathan NR
    NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
    Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
    Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion-weighted breast imaging at 3 T: preliminary experience.
    Nogueira L; Brandão S; Matos E; Nunes RG; Ferreira HA; Loureiro J; Ramos I
    Clin Radiol; 2014 Apr; 69(4):378-84. PubMed ID: 24360516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
    Pinker K; Bogner W; Baltzer P; Karanikas G; Magometschnigg H; Brader P; Gruber S; Bickel H; Dubsky P; Bago-Horvath Z; Bartsch R; Weber M; Trattnig S; Helbich TH
    Clin Cancer Res; 2014 Jul; 20(13):3540-9. PubMed ID: 24963052
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo MR spectroscopic imaging of polyunsaturated fatty acids (PUFA) in healthy and cancerous breast tissues by selective multiple-quantum coherence transfer (Sel-MQC): a preliminary study.
    He Q; Shkarin P; Hooley RJ; Lannin DR; Weinreb JC; Bossuyt VI
    Magn Reson Med; 2007 Dec; 58(6):1079-85. PubMed ID: 17969083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
    Shin HJ; Baek HM; Cha JH; Kim HH
    AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
    Başara I; Örgüç Ş; Coşkun T
    Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
    Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
    J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
    Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.